MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

movapo pfs apomorphine hydrochloride hemihydrate 50mg/10ml solution for subcutaneous infusion pre-filled syringe

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

CRESP MCG PFS INJ (PFS) India - English - Central Drugs Standard Control Organization

cresp mcg pfs inj (pfs)

dr. reddy's - darbepoetin alpha - inj (pfs) - 25mcg - (r-dna origin) 25mcg - pfs

CRESP MCG PFS INJ (PFS) India - English - Central Drugs Standard Control Organization

cresp mcg pfs inj (pfs)

dr. reddy's - darbepoetin alpha - inj (pfs) - 40mcg - (r-dna origin) 25mcg - pfs

LOMORIN 5*0.4ML(PFS) INJ PFS India - English - Central Drugs Standard Control Organization

lomorin 5*0.4ml(pfs) inj pfs

vhb - l m w h - inj pfs - 40mg/0.4ml(gensparin sod.) - 5*0.4ml(pfs)

AMGEVITA 20 mg in 0.4 ml ( 50 mg/ml ) SYR/1 PFS BOX Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

amgevita 20 mg in 0.4 ml ( 50 mg/ml ) syr/1 pfs box

مستودع أدوية أداتكو - adatco drug store - adalimumab 20 mg in 0.4 ml ( 50 mg/ml ) syr/1 pfs box - 20 mg in 0.4 ml ( 50 mg/ml ) syr/1 pfs box

Amgevita 40 mg in 0.8 ml ( 50 mg/ml ) SYR/2 PFS BOX Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

amgevita 40 mg in 0.8 ml ( 50 mg/ml ) syr/2 pfs box

مستودع أدوية أداتكو - adatco drug store - adalimumab 40 mg in 0.8 ml ( 50 mg/ml ) syr/2 pfs box - 40 mg in 0.8 ml ( 50 mg/ml ) syr/2 pfs box

APO-GO PFS 5 Mg/Ml Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

apo-go pfs 5 mg/ml solution for infusion

genus pharmaceuticals limited - apomorphine hydrochloride - solution for infusion - 5 mg/ml

Apo-go PFS Solution for Infusion 5mg/ml Malta - English - Medicines Authority

apo-go pfs solution for infusion 5mg/ml

britannia pharmaceuticals limited - apomorphine hydrochloride - solution for infusion - apomorphine hydrochloride 5 mg/ml - anti-parkinson drugs

APO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe*Abbreviated to APO-go in the text Ireland - English - HPRA (Health Products Regulatory Authority)

apo-go® pfs 5mg/ml solution for infusion in pre-filled syringe*abbreviated to apo-go in the text

britannia pharmaceuticals ltd - apomorphine hydrochloride - solution for infusion in pre-filled syringe - 5 milligram(s)/millilitre - dopamine agonists; apomorphine

METHOBLASTIN PFS methotrexate as sodium 25 mg/1 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

methoblastin pfs methotrexate as sodium 25 mg/1 ml solution for injection pre-filled syringe

pfizer australia pty ltd - methotrexate -